The study found treatment with investigational drug, NXY059, resulted in a significant reduction in disability of stroke patients compared to treatment with a placebo.
This is the first positive study of a neuro-protectant, an emerging class of drugs currently being investigated as stroke treatments.
They may play a role in preventing or minimizing damage to brain tissue thereby reducing disability following an acute ischemic stroke.
Stroke is the number one cause of disability in the U.S. for adult Americans, affecting 700,000 Americans every year.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.